WO2015027847A3 - 含有奥司他韦羧酸胍基类似体和/或其乙酯制剂的给药方法 - Google Patents
含有奥司他韦羧酸胍基类似体和/或其乙酯制剂的给药方法 Download PDFInfo
- Publication number
- WO2015027847A3 WO2015027847A3 PCT/CN2014/084835 CN2014084835W WO2015027847A3 WO 2015027847 A3 WO2015027847 A3 WO 2015027847A3 CN 2014084835 W CN2014084835 W CN 2014084835W WO 2015027847 A3 WO2015027847 A3 WO 2015027847A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- guanidino
- analogues
- preparation containing
- ethyl esters
- administration method
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Otolaryngology (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
一种含奥司他韦羧酸胍基类似体和/或其乙酯的制剂通过吸入进行给药的方法。所述方法可以治疗流行性感冒病毒引起的感冒，是一种药物剂量小，副作用少，起效快的方法。所述给药通过干粉、喷粉器、定量剂量吸入器或雾化器中的一种或两种以上方式进行。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310376245.X | 2013-08-26 | ||
| CN201310376245XA CN103446078A (zh) | 2013-08-26 | 2013-08-26 | 含有奥司他韦羧酸胍基类似体和/或其乙酯制剂的给药方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2015027847A2 WO2015027847A2 (zh) | 2015-03-05 |
| WO2015027847A3 true WO2015027847A3 (zh) | 2015-04-23 |
Family
ID=49729200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/CN2014/084835 WO2015027847A2 (zh) | 2013-08-26 | 2014-08-20 | 含有奥司他韦羧酸胍基类似体和/或其乙酯制剂的给药方法 |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN103446078A (zh) |
| WO (1) | WO2015027847A2 (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2592376A (en) * | 2020-02-25 | 2021-09-01 | Aer Beatha Ltd | Canister |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009143011A1 (en) * | 2008-05-20 | 2009-11-26 | Novartis Ag | Antiviral compositions, methods of making and using such compositions, and systems for pulmonary delivery of such compositions |
| WO2011035128A1 (en) * | 2009-09-17 | 2011-03-24 | Mutual Pharmaceutical Company, Inc. | Method of treating asthma with antiviral agents |
-
2013
- 2013-08-26 CN CN201310376245XA patent/CN103446078A/zh active Pending
-
2014
- 2014-08-20 WO PCT/CN2014/084835 patent/WO2015027847A2/zh active Application Filing
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009143011A1 (en) * | 2008-05-20 | 2009-11-26 | Novartis Ag | Antiviral compositions, methods of making and using such compositions, and systems for pulmonary delivery of such compositions |
| WO2011035128A1 (en) * | 2009-09-17 | 2011-03-24 | Mutual Pharmaceutical Company, Inc. | Method of treating asthma with antiviral agents |
Non-Patent Citations (1)
| Title |
|---|
| LI, WEIXING ET AL.: "Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY., vol. 42, no. 3, 31 March 1998 (1998-03-31) * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103446078A (zh) | 2013-12-18 |
| WO2015027847A2 (zh) | 2015-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1120605T1 (el) | Παρασκευασμα ξηρης σκονης που περιλαμβανει εναν αναστολεα φωσφοδιεστερασης | |
| AR098640A1 (es) | Inhalador de polvo seco | |
| EA201591729A1 (ru) | Пригодные для вдыхания агломераты частиц пористого носителя и тонкоизмельченного лекарственного средства | |
| MX2021002579A (es) | Formulaciones de sal de nicotina para dispositivos de aerosol y metodos de los mismos. | |
| TN2012000566A1 (en) | Dry powder formulation comprising an antimuscarinic drug | |
| WO2015054124A3 (en) | Dry powder inhaler | |
| JP2013224331A5 (zh) | ||
| WO2012041938A3 (en) | Inhaler | |
| MX2015011610A (es) | Nebulizador para bebes y pacientes con compromiso respiratorio. | |
| WO2012047182A3 (en) | Single dose dry powder inhalation device | |
| EA201590734A1 (ru) | Вдыхаемые лекарственные средства | |
| PH12014502746B1 (en) | Dry powder for inhalation formulation comprising salmeterol xinafoate, fluticasone propionate and tiotropium bromide, and method for preparing same | |
| EA201590286A1 (ru) | Аэрозольное ингаляционное устройство | |
| EA201591869A1 (ru) | Композиция, содержащая для повышения стабильности лекарственной формы по меньшей мере два сухих порошка, получаемых распылительной сушкой | |
| EP4233874A3 (en) | Acetylsalicylic acid for reducing the risk of a thromboembolic event | |
| MX2015015132A (es) | Composiciones farmaceuticas inhalables y los dispositivos inhaladores que las contienen. | |
| WO2014007770A3 (en) | Inhalation compositions comprising corticosteroid and sorbitol | |
| WO2013104892A8 (en) | Application of high dose compounds via inhalation | |
| PH12014502662A1 (en) | Novel dosage form and formulation of abediterol | |
| MD20140131A2 (ro) | Doză şi formă preparativă nouă pentru inhalare care cuprinde aclidiniu | |
| WO2014007781A3 (en) | Inhalation compositions | |
| MX2015015150A (es) | Composiciones farmaceuticas inhalables y los dispositivos inhaladores que las contienen. | |
| EA201201390A1 (ru) | Кнопочное устройство мундштука ингалятора сухого порошка | |
| WO2015027847A3 (zh) | 含有奥司他韦羧酸胍基类似体和/或其乙酯制剂的给药方法 | |
| PL3956001T3 (pl) | Urządzenie do jednoczesnego podawania tlenu i leków z inhalatora z odmierzaną dawką przez inhalację |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 14839005 Country of ref document: EP Kind code of ref document: A2 |